A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer
A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer
Recruiting · NCT07281976 · Registry updated 2026-02-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 1 / Phase 2 | 2026-02-12 | NCT07281976 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nanjing Leads Biolabs Co.,Ltd | 13 |
| The First Affiliated Hospital with Nanjing Medical University | 319 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Harbin Medical University Cancer Hospital | Harbin | China | 102 |
| Henan Cancer Hospital | Zhengzhou | China | 76 |
| Jiangsu Province Hospital | Nanjing | China | 89 |
| Liaoning Cancer Hospital | Shenyang | China | 10 |
| Sun Yat-sen Memorial Hospital, Sun Yat-sen University | Guangzhou | China | 67 |
| Sun Yat-sen University Cancer Center | Guangzhou | China | 7 |
| The First Hospital of Jilin University | Changchun | China | 110 |